{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:27:02Z","timestamp":1783524422582,"version":"3.55.0"},"reference-count":162,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020247","name":"University of Bisha","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020247","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.arr.2025.102684","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T16:34:22Z","timestamp":1738686862000},"page":"102684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Beyond amyloid plaque, targeting \u03b1-synuclein in Alzheimer disease: The battle continues"],"prefix":"10.1016","volume":"105","author":[{"given":"Hayder M.","family":"Al-kuraishy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6388-3849","authenticated-orcid":false,"given":"Ghassan M.","family":"Sulaiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamdoon A.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali I.","family":"Al-Gareeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali K.","family":"Albuhadily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amer Al","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed H.","family":"Abu-Alghayth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2025.102684_bib1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00401-009-0523-2","article-title":"Staging\/typing of Lewy body related \u03b1-synuclein pathology: a study of the BrainNet Europe Consortium","volume":"117","author":"Alafuzoff","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2025.102684_bib2","doi-asserted-by":"crossref","unstructured":"Alecu, J.E., Sigutova, V., Brazdis, R.-M., Loerentz, S., Bogionko, M., Nursaitova, A., Regensburger, M., Roybon, L., Galler, K.M., Wrasidlo, W., 2023. NPT100-18A reduces mitochondrial oxidative stress and rescues neuronal cell death in a human iPSC-based model of Parkinson\u2019s disease.","DOI":"10.21203\/rs.3.rs-3311240\/v1"},{"key":"10.1016\/j.arr.2025.102684_bib3","first-page":"1","article-title":"A mutual nexus between epilepsy and \u03b1-synuclein: a puzzle pathway","author":"Ali","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2025.102684_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.17993","article-title":"Neprilysin inhibitors and risk of Alzheimer\u2019s disease: a future perspective","volume":"28","author":"Ali","year":"2024","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.arr.2025.102684_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14521","article-title":"Sleep disorders cause Parkinson\u2019s disease or the reverse is true: good GABA good night","volume":"30","author":"Al-kuraishy","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.arr.2025.102684_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102084","article-title":"The link between Alzheimer disease and metabolic syndrome: a mutual relationship and long rigorous investigation","author":"Al-Kuraishy","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2025.102684_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102119","article-title":"Evaluation and targeting of amyloid precursor protein (APP)\/amyloid beta (A\u03b2) axis in amyloidogenic and non-amyloidogenic pathways: a time outside the tunnel","author":"Al-Kuraishy","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2025.102684_bib8","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1080\/15548627.2024.2315893","article-title":"Defective autophagy and autophagy activators in Myasthenia Gravis: a rare entity and unusual scenario","volume":"20","author":"Al-Kuraishy","year":"2024","journal-title":"Autophagy"},{"key":"10.1016\/j.arr.2025.102684_bib9","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.3390\/polym13234146","article-title":"Emerging application of magnetic nanoparticles for diagnosis and treatment of cancer","volume":"13","author":"Alromi","year":"2021","journal-title":"Polymers"},{"key":"10.1016\/j.arr.2025.102684_bib10","article-title":"Metformin role in Parkinson\u2019s disease: a double-sword effect","author":"Alrouji","year":"2023","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.arr.2025.102684_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci12101290","article-title":"Statins use in Alzheimer disease: bane or boon from frantic search and narrative review","volume":"12","author":"Alsubaie","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.arr.2025.102684_bib12","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0006-8993(00)03082-1","article-title":"\u03b1-Synuclein-positive structures in cases with sporadic Alzheimer\u2019s disease: morphology and its relationship to tau aggregation","volume":"888","author":"Arai","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.arr.2025.102684_bib13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1021\/acschemneuro.5b00204","article-title":"Non-amyloid-\u03b2 component of human \u03b1-synuclein oligomers induces formation of new A\u03b2 oligomers: insight into the mechanisms that link Parkinson\u2019s and Alzheimer\u2019s diseases","volume":"7","author":"Atsmon-Raz","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2025.102684_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2050-6511-15-23","article-title":"Safety and pharmacological characterization of the molecular tweezer CLR01\u2013a broad-spectrum inhibitor of amyloid proteins\u2019 toxicity","volume":"15","author":"Attar","year":"2014","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.arr.2025.102684_bib15","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1124\/jpet.114.219352","article-title":"Complex disposition of methylthioninium redox forms determines efficacy in tau aggregation inhibitor therapy for Alzheimer\u2019s disease","volume":"352","author":"Baddeley","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.arr.2025.102684_bib16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/jnnp-2022-329124","article-title":"Cerebrospinal fluid \u03b2-synuclein as a synaptic biomarker for preclinical Alzheimer\u2019s disease","volume":"94","author":"Barba","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2025.102684_bib17","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neuron.2019.10.010","article-title":"Amyloid-beta (A\u03b2) plaques promote seeding and spreading of alpha-synuclein and tau in a mouse model of Lewy body disorders with A\u03b2 pathology","volume":"105","author":"Bassil","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2025.102684_bib18","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.3389\/fnins.2019.01399","article-title":"Alpha-synuclein physiology and pathology: a perspective on cellular structures and organelles","volume":"13","author":"Bernal-Conde","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2025.102684_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.666585","article-title":"\u03b1-Synuclein: an all-inclusive trip around its structure, influencing factors and applied techniques","volume":"9","author":"Bisi","year":"2021","journal-title":"Front. Chem."},{"key":"10.1016\/j.arr.2025.102684_bib20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/bs.acc.2020.08.007","article-title":"Synuclein in neurodegeneration","volume":"103","author":"Bougea","year":"2021","journal-title":"Adv. Clin. Chem."},{"key":"10.1016\/j.arr.2025.102684_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-33474-z","article-title":"Lipid-dependent deposition of alpha-synuclein and Tau on neuronal Secretogranin II-positive vesicular membranes with age","volume":"8","author":"Brekk","year":"2018","journal-title":"Sci. Rep."},{"issue":"80","key":"10.1016\/j.arr.2025.102684_bib22","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1126\/science.1195227","article-title":"\u03b1-Synuclein promotes SNARE-complex assembly in vivo and in vitro","volume":"329","author":"Burr\u00e9","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.arr.2025.102684_bib23","doi-asserted-by":"crossref","first-page":"E4274","DOI":"10.1073\/pnas.1416598111","article-title":"\u03b1-Synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation","volume":"111","author":"Burr\u00e9","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2025.102684_bib24","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3934\/Neuroscience.2021005","article-title":"The biological pathways of Alzheimer disease: A review","volume":"8","author":"Calabr\u00f2","year":"2021","journal-title":"AIMS Neurosci."},{"key":"10.1016\/j.arr.2025.102684_bib25","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1080\/15548627.2023.2175569","article-title":"Rapamycin and Alzheimer disease: a hypothesis for the effective use of rapamycin for treatment of neurodegenerative disease","volume":"19","author":"Carosi","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.arr.2025.102684_bib26","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neulet.2016.11.022","article-title":"Activation of \u03b22-adrenergic receptor promotes dendrite ramification and spine generation in APP\/PS1 mice","volume":"636","author":"Chai","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2025.102684_bib27","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.bj.2021.12.010","article-title":"Phosphorylated \u03b1-synuclein in diluted human serum as a biomarker for Parkinson\u2019s disease","volume":"45","author":"Chen","year":"2022","journal-title":"Biomed. J."},{"key":"10.1016\/j.arr.2025.102684_bib28","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.pneurobio.2010.01.002","article-title":"Epigenetic regulation in the pathophysiology of Alzheimer\u2019s disease","volume":"90","author":"Chouliaras","year":"2010","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.arr.2025.102684_bib29","doi-asserted-by":"crossref","first-page":"10809","DOI":"10.3390\/ijms241310809","article-title":"Unraveling molecular and genetic insights into neurodegenerative diseases: Advances in understanding Alzheimer\u2019s, Parkinson\u2019s, and Huntington\u2019s diseases and amyotrophic lateral sclerosis","volume":"24","author":"Ciurea","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102684_bib30","doi-asserted-by":"crossref","first-page":"22618","DOI":"10.1074\/jbc.M116.739250","article-title":"Small heat-shock proteins prevent \u03b1-synuclein aggregation via transient interactions and their efficacy is affected by the rate of aggregation","volume":"291","author":"Cox","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2025.102684_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.999666","article-title":"Associations between the use of \u03b2-adrenoceptor acting drugs and the risk of dementia in older population","volume":"13","author":"Cui","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.arr.2025.102684_bib32","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/j.bbagen.2015.05.021","article-title":"Anle138b and related compounds are aggregation specific fluorescence markers and reveal high affinity binding to \u03b1-synuclein aggregates","volume":"1850","author":"Deeg","year":"2015","journal-title":"Biochim. Biophys. Acta (BBA)-Gen. Subj."},{"key":"10.1016\/j.arr.2025.102684_bib33","first-page":"L3","article-title":"Amelioration of tau pathology by anle138b rescues neuronal function in a mouse model of human Alzheimer\u2019s disease tau","volume":"58","author":"Deussing","year":"2019","journal-title":"Nukl. -Nucl."},{"key":"10.1016\/j.arr.2025.102684_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag0481","article-title":"Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy","volume":"9","author":"DeVos","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.arr.2025.102684_bib35","first-page":"1","article-title":"The molecular tweezer CLR01 improves behavioral deficits and reduces tau pathology in P301S-tau transgenic mice","volume":"13","author":"Di","year":"2021","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.arr.2025.102684_bib36","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1073\/pnas.242720499","article-title":"Chaperones increase association of tau protein with microtubules","volume":"100","author":"Dou","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2025.102684_bib37","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/ene.14032","article-title":"The value of cerebrospinal fluid \u03b1-synuclein and the tau\/\u03b1-synuclein ratio for diagnosis of neurodegenerative disorders with Lewy pathology","volume":"27","author":"F\u00f8rland","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.arr.2025.102684_bib38","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1212\/WNL.94.15_supplement.5357","article-title":"Nilotinib alters microRNAs that regulate specific autophagy and ubiquitination genes in the CSF of individuals with Parkinson\u2019s disease (5357)","volume":"94","author":"Fowler","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2025.102684_bib39","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac072","article-title":"Neurochemical and cognitive changes precede structural abnormalities in the TgF344-AD rat model","volume":"4","author":"Fowler","year":"2022","journal-title":"Brain Commun."},{"key":"10.1016\/j.arr.2025.102684_bib40","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40478-023-01711-w","article-title":"Regional differences in synaptic degeneration are linked to alpha-synuclein burden and axonal damage in Parkinson\u2019s disease and dementia with Lewy bodies","volume":"12","author":"Frigerio","year":"2024","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.arr.2025.102684_bib41","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nn2058","article-title":"A molecular pathway of neurodegeneration linking \u03b1-synuclein to ApoE and A\u03b2 peptides","volume":"11","author":"Gallardo","year":"2008","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.arr.2025.102684_bib42","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/jnc.14719","article-title":"Measurement of CSF \u03b1-synuclein improves early differential diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease","volume":"150","author":"Garc\u00eda-Ayll\u00f3n","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2025.102684_bib43","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3390\/biomedicines10020371","article-title":"Emerging therapeutic strategies for Parkinson\u2019s disease and future prospects: A 2021 update","volume":"10","author":"Gouda","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.arr.2025.102684_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103691","article-title":"Antisense oligonucleotides for Alzheimer\u2019s disease therapy: from the mRNA to miRNA paradigm","volume":"74","author":"Grabowska-Pyrzewicz","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.arr.2025.102684_bib45","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.nbd.2018.11.015","article-title":"P\u03b1-syn*\u2009mitotoxicity is linked to MAPK activation and involves tau phosphorylation and aggregation at the mitochondria","volume":"124","author":"Grassi","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2025.102684_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.661612","article-title":"Pharmacological modulators of small GTPases of rho family in neurodegenerative diseases","volume":"15","author":"Guiler","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.arr.2025.102684_bib47","doi-asserted-by":"crossref","first-page":"651","DOI":"10.31083\/j.jin.2020.04.243","article-title":"Fasudil reduces \u03b2-amyloid levels and neuronal apoptosis in APP\/PS1 transgenic mice via inhibition of the Nogo-A\/NgR\/RhoA signaling axis","volume":"19","author":"Guo","year":"2020","journal-title":"J. Integr. Neurosci."},{"key":"10.1016\/j.arr.2025.102684_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.648151","article-title":"Genetic analysis and literature review of SNCA variants in Parkinson\u2019s disease","volume":"13","author":"Guo","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2025.102684_bib49","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/s41380-021-01296-7","article-title":"Brain regions susceptible to alpha-synuclein spreading","volume":"27","author":"Guo","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.arr.2025.102684_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.743754","article-title":"Parkinson\u2019s disease dementia: synergistic effects of alpha-synuclein, tau, beta-amyloid, and iron","volume":"13","author":"Han","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2025.102684_bib51","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/bph.15684","article-title":"Targeting \u03b1-synuclein aggregation and its role in mitochondrial dysfunction in Parkinson\u2019s disease","volume":"179","author":"Haque","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.arr.2025.102684_bib52","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/mds.27562","article-title":"Anle138b modulates \u03b1-synuclein oligomerization and prevents motor decline and neurodegeneration in a mouse model of multiple system atrophy","volume":"34","author":"Heras-Garvin","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2025.102684_bib53","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.bbrc.2021.03.091","article-title":"Tau induces formation of \u03b1-synuclein filaments with distinct molecular conformations","volume":"554","author":"Hojjatian","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.arr.2025.102684_bib54","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1001\/archneur.63.2.226","article-title":"Relation of quantitative indexes of concurrent \u03b1-synuclein abnormalities to clinical outcome in autopsy-proven Alzheimer disease","volume":"63","author":"Holtzer","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.arr.2025.102684_bib55","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/sj.gt.3302719","article-title":"Herpes simplex virus RNAi and neprilysin gene transfer vectors reduce accumulation of Alzheimer\u2019s disease-related amyloid-\u03b2 peptide in vivo","volume":"13","author":"Hong","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.arr.2025.102684_bib56","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1523\/JNEUROSCI.5478-10.2011","article-title":"Suppression of Alzheimer\u2019s disease-related phenotypes by expression of heat shock protein 70 in mice","volume":"31","author":"Hoshino","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2025.102684_bib57","series-title":"in: Neurology","first-page":"3201","article-title":"Natural Statins as Inhibitors of Alpha-synuclein Fibril Formation (P7-3.012)","author":"Hwang","year":"2024"},{"key":"10.1016\/j.arr.2025.102684_bib58","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1001\/jamaneurol.2018.1487","article-title":"Safety and tolerability of multiple ascending doses of PRX002\/RG7935, an anti\u2013\u03b1-synuclein monoclonal antibody, in patients with Parkinson disease: a randomized clinical trial","volume":"75","author":"Jankovic","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2025.102684_bib59","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9966223","article-title":"Neuroprotective Effects of Palmatine via the Enhancement of Antioxidant Defense and Small Heat Shock Protein Expression in A\u03b2-Transgenic Caenorhabditis elegans","volume":"2021","author":"Jia","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.arr.2025.102684_bib60","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/tox.22842","article-title":"Protective effects of trehalose against Mn-induced \u03b1-synuclein oligomerization in mice: Involvement of oxidative stress and autophagy","volume":"35","author":"Jing","year":"2020","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.arr.2025.102684_bib61","doi-asserted-by":"crossref","first-page":"8311","DOI":"10.3390\/ijms23158311","article-title":"Neuronal ApoE Regulates the Cell-to-Cell Transmission of \u03b1-Synuclein","volume":"23","author":"Kang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102684_bib62","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1001\/jamaneurol.2020.1741","article-title":"Prevalence and clinical phenotype of quadruple misfolded proteins in older adults","volume":"77","author":"Karanth","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2025.102684_bib63","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41573-022-00391-w","article-title":"The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics","volume":"21","author":"Karran","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.arr.2025.102684_bib64","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1111\/j.1742-4658.2011.08389.x","article-title":"Stimulatory effect of \u03b1-synuclein on the tau-phosphorylation by GSK-3\u03b2","volume":"278","author":"Kawakami","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.arr.2025.102684_bib65","doi-asserted-by":"crossref","DOI":"10.1002\/bies.201900195","article-title":"Trehalose against Alzheimer\u2019s disease: insights into a potential therapy","volume":"42","author":"Khalifeh","year":"2020","journal-title":"BioEssays"},{"key":"10.1016\/j.arr.2025.102684_bib66","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.4103\/1673-5374.308085","article-title":"Therapeutic potential of trehalose in neurodegenerative diseases: The knowns and unknowns","volume":"16","author":"Khalifeh","year":"2021","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.arr.2025.102684_bib67","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00401-018-1886-z","article-title":"Bidirectional modulation of Alzheimer phenotype by alpha-synuclein in mice and primary neurons","volume":"136","author":"Khan","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2025.102684_bib68","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3233\/JAD-210607","article-title":"Potential mechanisms underlying resistance to dementia in non-demented individuals with Alzheimer\u2019s disease neuropathology","volume":"87","author":"Kok","year":"2022","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.arr.2025.102684_bib69","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3390\/brainsci12091237","article-title":"Alzheimer\u2019s disease and inflammaging","volume":"12","author":"Kosyreva","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.arr.2025.102684_bib70","first-page":"256","article-title":"Highly potent and specific GSK-3\u03b2 inhibitors that block tau phosphorylation and decrease \u03b1-synuclein protein expression in a cellular model of Parkinson\u2019s disease","volume":"1","author":"Kozikowski","year":"2006","journal-title":"ChemMedChem Chem. Enabling Drug Discov."},{"key":"10.1016\/j.arr.2025.102684_bib71","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/jnr.21352","article-title":"Enhanced accumulation of phosphorylated \u03b1-synuclein in double transgenic mice expressing mutant \u03b2-amyloid precursor protein and presenilin-1","volume":"85","author":"Kurata","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.arr.2025.102684_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2021.102031","article-title":"Nilotinib restores memory function by preventing dopaminergic neuron degeneration in a mouse model of Alzheimer\u2019s Disease","volume":"202","author":"La Barbera","year":"2021","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.arr.2025.102684_bib73","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1159\/000329763","article-title":"Decreased \u03b1-synuclein serum levels in patients with Lewy body dementia compared to Alzheimer\u2019s disease patients and control subjects","volume":"31","author":"Laske","year":"2011","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.arr.2025.102684_bib74","first-page":"141","article-title":"NPT088 reduces both amyloid-\u03b2 and tau pathologies in transgenic mice. Alzheimer\u2019s dement","volume":"2","author":"Levenson","year":"2016","journal-title":"Transl. Res. Clin. Inter."},{"key":"10.1016\/j.arr.2025.102684_bib75","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/archneur.63.3.370","article-title":"Lewy body pathology in familial Alzheimer disease: evidence for disease-and mutation-specific pathologic phenotype","volume":"63","author":"Leverenz","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.arr.2025.102684_bib76","doi-asserted-by":"crossref","DOI":"10.1002\/alz.13818","article-title":"\u03b1-Synuclein seed amplification assay detects Lewy body co-pathology in autosomal dominant Alzheimer\u2019s disease late in the disease course and dependent on Lewy pathology burden","author":"Levin","year":"2024","journal-title":"Alzheimer\u2019S. Dement"},{"key":"10.1016\/j.arr.2025.102684_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-3-19","article-title":"In vivo silencing of alpha-synuclein using naked siRNA","volume":"3","author":"Lewis","year":"2008","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2025.102684_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.937486","article-title":"Global, regional, and national burden of Alzheimer\u2019s disease and other dementias, 1990\u20132019","volume":"14","author":"Li","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2025.102684_bib79","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3389\/fnagi.2016.00254","article-title":"c-Abl inhibitors enable insights into the pathophysiology and neuroprotection in Parkinson\u2019s disease","volume":"8","author":"Lindholm","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2025.102684_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.738971","article-title":"Meta-analysis of neurochemical changes estimated via magnetic resonance spectroscopy in mild cognitive impairment and Alzheimer\u2019s disease","volume":"13","author":"Liu","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2025.102684_bib81","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1007\/s12035-020-01942-1","article-title":"Trehalose inhibits A\u03b2 generation and plaque formation in Alzheimer\u2019s disease","volume":"57","author":"Liu","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2025.102684_bib82","doi-asserted-by":"crossref","first-page":"5622","DOI":"10.1111\/bph.15275","article-title":"Rho kinase inhibitor fasudil reduces l-DOPA-induced dyskinesia in a rat model of Parkinson\u2019s disease","volume":"177","author":"Lopez-Lopez","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.arr.2025.102684_bib83","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nature13163","article-title":"REST and stress resistance in ageing and Alzheimer\u2019s disease","volume":"507","author":"Lu","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.arr.2025.102684_bib84","article-title":"The association between plasma \u03b1-synuclein (\u03b1-syn) protein, urinary Alzheimer-associated neuronal thread protein (AD7c-NTP), and apolipoprotein epsilon 4 (ApoE \u025b4) alleles and cognitive decline in 60 patients with Alzheimer\u2019s disease compared with 28 age","volume":"27","author":"Lv","year":"2021","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.arr.2025.102684_bib85","doi-asserted-by":"crossref","DOI":"10.1038\/srep40263","article-title":"Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer\u2019s disease","volume":"7","author":"Majbour","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2025.102684_bib86","first-page":"201","article-title":"Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer\u2019s disease","volume":"148","author":"Masliah","year":"1996","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.arr.2025.102684_bib87","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012122","article-title":"\u03b1-synuclein suppression by targeted small interfering RNA in the primate substantia nigra","volume":"5","author":"McCormack","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2025.102684_bib88","first-page":"869","article-title":"Endogenous alpha-synuclein is essential for the transfer of pathology by exosome-enriched extracellular vesicles, following inoculation with preformed fibrils in vivo","volume":"15","author":"Melachroinou","year":"2024","journal-title":"Aging Dis."},{"key":"10.1016\/j.arr.2025.102684_bib89","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/acn3.51482","article-title":"Quantifying regional \u03b1-synuclein, amyloid \u03b2, and tau accumulation in Lewy body dementia","volume":"9","author":"Miller","year":"2022","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.arr.2025.102684_bib90","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41419-023-05977-9","article-title":"Statins suppress cell-to-cell propagation of \u03b1-synuclein by lowering cholesterol","volume":"14","author":"Min","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.arr.2025.102684_bib91","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1126\/science.aaf3934","article-title":"\u03b22-Adrenoreceptor is a regulator of the \u03b1-synuclein gene driving risk of Parkinson\u2019s disease","volume":"357","author":"Mittal","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.arr.2025.102684_bib92","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1021\/cn500056q","article-title":"Lithium and autophagy","volume":"5","author":"Motoi","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2025.102684_bib93","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.3390\/biom13101435","article-title":"Autophagy in Parkinson\u2019s disease","volume":"13","author":"Nechushtai","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.arr.2025.102684_bib94","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1474-4422(18)30403-4","article-title":"Global, regional, and national burden of Alzheimer\u2019s disease and other dementias, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"Nichols","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2025.102684_bib95","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/mds.27297","article-title":"Multiple system atrophy and apolipoprotein E","volume":"33","author":"Ogaki","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2025.102684_bib96","first-page":"39","article-title":"Implication of alpha-synuclein phosphorylation at S129 in synucleinopathies: what have we learned in the last decade?","volume":"6","author":"Oueslati","year":"2016","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.arr.2025.102684_bib97","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41531-023-00509-w","article-title":"CSF neurochemical profile and cognitive changes in Parkinson\u2019s disease with mild cognitive impairment","volume":"9","author":"Paolini Paoletti","year":"2023","journal-title":"npj Park. Dis."},{"key":"10.1016\/j.arr.2025.102684_bib98","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/mds.23670","article-title":"Cerebrospinal fluid Tau\/\u03b1-synuclein ratio in Parkinson\u2019s disease and degenerative dementias","volume":"26","author":"Parnetti","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2025.102684_bib99","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1002\/alz.13109","article-title":"CSF alpha-synuclein aggregates by seed amplification and clinical presentation of AD","volume":"19","author":"Pilotto","year":"2023","journal-title":"Alzheimer\u2019S. Dement"},{"key":"10.1016\/j.arr.2025.102684_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105148","article-title":"Lithium engages autophagy for neuroprotection and neuroplasticity: Translational evidence for therapy","volume":"148","author":"Puglisi-Allegra","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.arr.2025.102684_bib101","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/jnc.13256","article-title":"Mitochondrial impairment and oxidative stress compromise autophagosomal degradation of \u03b1-synuclein in oligodendroglial cells","volume":"135","author":"Puka\u00df","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2025.102684_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2022.173406","article-title":"Combined induction of mTOR-dependent and mTOR-independent pathways of autophagy activation as an experimental therapy for Alzheimer\u2019s disease-like pathology in a mouse model","volume":"217","author":"Pupyshev","year":"2022","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.arr.2025.102684_bib103","doi-asserted-by":"crossref","first-page":"5055","DOI":"10.1074\/jbc.M110.178905","article-title":"Parkinsonian neurotoxin 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) and \u03b1-synuclein mutations promote tau protein phosphorylation at Ser262 and destabilize microtubule cytoskeleton in vitro","volume":"286","author":"Qureshi","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2025.102684_bib104","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jnc.15134","article-title":"Dopamine promotes the neurodegenerative potential of \u03b2-synuclein","volume":"156","author":"Raina","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2025.102684_bib105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12877-021-02130-z","article-title":"The effect of comorbidities on survival in persons with Alzheimer\u2019s disease: a matched cohort study","volume":"21","author":"Rajamaki","year":"2021","journal-title":"BMC Geriatr."},{"key":"10.1016\/j.arr.2025.102684_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2022.105311","article-title":"mTOR signaling as a molecular target for the alleviation of Alzheimer\u2019s disease pathogenesis","volume":"155","author":"Rapaka","year":"2022","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.arr.2025.102684_bib107","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1016\/j.jmb.2019.04.019","article-title":"The molecular basis for apolipoprotein E4 as the major risk factor for late-onset Alzheimer\u2019s disease","volume":"431","author":"Raulin","year":"2019","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.arr.2025.102684_bib108","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s11064-013-0982-7","article-title":"Effect of \u03b1-synuclein on amyloid \u03b2-induced toxicity: relevance to Lewy body variant of Alzheimer disease","volume":"38","author":"Resende","year":"2013","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.arr.2025.102684_bib109","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171925","article-title":"\u03b1-Synuclein increases \u03b2-amyloid secretion by promoting \u03b2-\/\u03b3-secretase processing of APP","volume":"12","author":"Roberts","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2025.102684_bib110","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/978-981-32-9358-8_15","article-title":"Associations between APOE variants, tau and \u03b1-synuclein","author":"Rodriguez-Vieitez","year":"2019","journal-title":"Tau Biol."},{"key":"10.1016\/j.arr.2025.102684_bib111","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/NEN.0b013e31829768d2","article-title":"\u03b1-Synuclein vaccination prevents the accumulation of parkinson disease-like pathologic inclusions in striatum in association with regulatory T cell recruitment in a rat model","volume":"72","author":"Sanchez-Guajardo","year":"2013","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.arr.2025.102684_bib112","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.expneurol.2005.12.024","article-title":"Silencing of human \u03b1-synuclein in vitro and in rat brain using lentiviral-mediated RNAi","volume":"198","author":"Sapru","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.arr.2025.102684_bib113","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1515\/revneuro-2012-0071","article-title":"The role of Ser129 phosphorylation of \u03b1-synuclein in neurodegeneration of Parkinson\u2019s disease: a review of in vivo models","volume":"24","author":"Sato","year":"2013","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.arr.2025.102684_bib114","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer\u2019s disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2025.102684_bib115","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/mds.26878","article-title":"First-in-human assessment of PRX002, an anti\u2013\u03b1-synuclein monoclonal antibody, in healthy volunteers","volume":"32","author":"Schenk","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2025.102684_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104760","article-title":"Immunotherapy for Parkinson\u2019s disease","volume":"137","author":"Schwab","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2025.102684_bib117","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3389\/fnmol.2017.00447","article-title":"A protein aggregation inhibitor, leuco-methylthioninium bis (hydromethanesulfonate), decreases \u03b1-synuclein inclusions in a transgenic mouse model of synucleinopathy","volume":"10","author":"Schwab","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.arr.2025.102684_bib118","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3233\/JAD-181152","article-title":"Cerebrospinal fluid and plasma biomarkers in neurodegenerative diseases","volume":"68","author":"Seino","year":"2019","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.arr.2025.102684_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2022.102270","article-title":"Amyloid \u03b2, Tau, and \u03b1-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases","volume":"214","author":"Sengupta","year":"2022","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.arr.2025.102684_bib120","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3389\/fneur.2017.00720","article-title":"Elevated serum \u03b1-synuclein autoantibodies in patients with parkinson\u2019s disease relative to Alzheimer\u2019s disease and controls","volume":"8","author":"Shalash","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.arr.2025.102684_bib121","doi-asserted-by":"crossref","first-page":"39962","DOI":"10.1074\/jbc.M505524200","article-title":"Geldanamycin induces heat shock protein 70 and protects against MPTP-induced dopaminergic neurotoxicity in mice","volume":"280","author":"Shen","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2025.102684_bib122","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.jalz.2018.02.015","article-title":"Cerebrospinal fluid \u03b1-synuclein contributes to the differential diagnosis of Alzheimer\u2019s disease","volume":"14","author":"Shi","year":"2018","journal-title":"Alzheimer\u2019S. Dement"},{"key":"10.1016\/j.arr.2025.102684_bib123","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s13273-020-00104-7","article-title":"Decreased plasma \u03b1-synuclein in idiopathic Parkinson\u2019s disease patients after adjusting hemolysis factor","volume":"16","author":"Shim","year":"2020","journal-title":"Mol. Cell. Toxicol."},{"key":"10.1016\/j.arr.2025.102684_bib124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-020-00648-9","article-title":"CSF total tau\/\u03b1-synuclein ratio improved the diagnostic performance for Alzheimer\u2019s disease as an indicator of tau phosphorylation","volume":"12","author":"Shim","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.arr.2025.102684_bib125","doi-asserted-by":"crossref","first-page":"e506","DOI":"10.1212\/WNL.0000000000013107","article-title":"Association of neurofibrillary tangle distribution with age at onset\u2013related clinical heterogeneity in Alzheimer disease: An autopsy study","volume":"98","author":"Smirnov","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2025.102684_bib126","doi-asserted-by":"crossref","first-page":"32701","DOI":"10.1073\/pnas.2013652117","article-title":"A dual role for \u03b1-synuclein in facilitation and depression of dopamine release from substantia nigra neurons in vivo","volume":"117","author":"Somayaji","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2025.102684_bib127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-019-0787-2","article-title":"Unique \u03b1-synuclein pathology within the amygdala in Lewy body dementia: implications for disease initiation and progression","volume":"7","author":"Sorrentino","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.arr.2025.102684_bib128","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.nbd.2019.03.001","article-title":"Systemic peptide mediated delivery of an siRNA targeting \u03b1-syn in the CNS ameliorates the neurodegenerative process in a transgenic model of Lewy body disease","volume":"127","author":"Spencer","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2025.102684_bib129","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3233\/JAD-190069","article-title":"Impact of pre-analytical differences on biomarkers in the ADNI and PPMI studies: implications in the era of classifying disease based on biomarkers","volume":"69","author":"Stewart","year":"2019","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.arr.2025.102684_bib130","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3390\/mi12020208","article-title":"Recent advances in in vivo neurochemical monitoring","volume":"12","author":"Tan","year":"2021","journal-title":"Micromachines"},{"key":"10.1016\/j.arr.2025.102684_bib131","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1021\/acschemneuro.0c00154","article-title":"Circular dichroism spectroscopy identifies the \u03b2-adrenoceptor agonist salbutamol as a direct inhibitor of tau filament formation in vitro","volume":"11","author":"Townsend","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2025.102684_bib132","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003135","article-title":"Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"3","author":"Tsigelny","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2025.102684_bib133","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13024-019-0320-x","article-title":"\u03b1-synuclein in the pathophysiology of Alzheimer\u2019s disease","volume":"14","author":"Twohig","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2025.102684_bib134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-018-0624-z","article-title":"The relevance of cerebrospinal fluid \u03b1-synuclein levels to sporadic and familial Alzheimer\u2019s disease","volume":"6","author":"Twohig","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.arr.2025.102684_bib135","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41582-022-00749-z","article-title":"Synaptic degeneration in Alzheimer disease","volume":"19","author":"Tzioras","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2025.102684_bib136","doi-asserted-by":"crossref","first-page":"11282","DOI":"10.1073\/pnas.90.23.11282","article-title":"Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease","volume":"90","author":"Ueda","year":"1993","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2025.102684_bib137","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/alz.12204","article-title":"An examination of a novel multipanel of CSF biomarkers in the Alzheimer\u2019s disease clinical and pathological continuum","volume":"17","author":"Van Hulle","year":"2021","journal-title":"Alzheimer\u2019S. Dement"},{"key":"10.1016\/j.arr.2025.102684_bib138","doi-asserted-by":"crossref","first-page":"6342","DOI":"10.1039\/C9AN00751B","article-title":"Simultaneous quantification of tau and \u03b1-synuclein in cerebrospinal fluid by high-resolution mass spectrometry for differentiation of Lewy Body Dementia from Alzheimer\u2019s Disease and controls","volume":"144","author":"Viod\u00e9","year":"2019","journal-title":"Analyst"},{"key":"10.1016\/j.arr.2025.102684_bib139","article-title":"Preventing Alzheimer\u2019s disease within reach by 2025: Targeted-risk-AD-prevention (TRAP) strategy","volume":"7","author":"Vitali","year":"2021","journal-title":"Alzheimer\u2019S. Dement. Transl. Res. Clin. Interv."},{"key":"10.1016\/j.arr.2025.102684_bib140","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00401-013-1114-9","article-title":"Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson\u2019s disease","volume":"125","author":"Wagner","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2025.102684_bib141","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/gerona\/glab142","article-title":"Rapamycin activates mitophagy and alleviates cognitive and synaptic plasticity deficits in a mouse model of Alzheimer\u2019s disease","volume":"76","author":"Wang","year":"2021","journal-title":"J. Gerontol. Ser. A"},{"key":"10.1016\/j.arr.2025.102684_bib142","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2020.571437","article-title":"Differential circulating levels of naturally occurring antibody to \u03b1-synuclein in Parkinson\u2019s disease dementia, Alzheimer\u2019s disease, and vascular dementia","volume":"12","author":"Wang","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2025.102684_bib143","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.neurobiolaging.2007.12.004","article-title":"Inhibition of LTP by beta-amyloid is prevented by activation of \u03b22 adrenoceptors and stimulation of the cAMP\/PKA signalling pathway","volume":"30","author":"Wang","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2025.102684_bib144","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/jcla.21986","article-title":"SNCA gene polymorphism may contribute to an increased risk of Alzheimer\u2019s disease","volume":"30","author":"Wang","year":"2016","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.arr.2025.102684_bib145","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.4103\/1673-5374.335827","article-title":"Advantages of Rho-associated kinases and their inhibitor fasudil for the treatment of neurodegenerative diseases","volume":"17","author":"Wang","year":"2022","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.arr.2025.102684_bib146","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.nbd.2018.10.016","article-title":"Development of an aggregate-selective, human-derived \u03b1-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson\u2019s disease models","volume":"124","author":"Weihofen","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2025.102684_bib147","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3233\/JAD-170560","article-title":"Potential of low dose leuco-methylthioninium bis (hydromethanesulphonate)(LMTM) monotherapy for treatment of mild Alzheimer\u2019s disease: Cohort analysis as modified primary outcome in a phase III clinical trial","volume":"61","author":"Wilcock","year":"2018","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.arr.2025.102684_bib148","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1093\/brain\/awu119","article-title":"Convergence of pathology in dementia with Lewy bodies and Alzheimer\u2019s disease: a role for the novel interaction of alpha-synuclein and presenilin 1 in disease","volume":"137","author":"Winslow","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.arr.2025.102684_bib149","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1093\/brain\/aww238","article-title":"A de novo compound targeting \u03b1-synuclein improves deficits in models of Parkinson\u2019s disease","volume":"139","author":"Wrasidlo","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.arr.2025.102684_bib150","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2015-310548","article-title":"Meta-analysis of modifiable risk factors for Alzheimer\u2019s disease","author":"Xu","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry 86, 1299\u20131306."},{"key":"10.1016\/j.arr.2025.102684_bib151","first-page":"969","article-title":"Fasudil promotes \u03b1-synuclein clearance in an AAV-mediated \u03b1-synuclein rat model of Parkinson\u2019s disease by autophagy activation","volume":"10","author":"Yang","year":"2020","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.arr.2025.102684_bib152","doi-asserted-by":"crossref","first-page":"7262","DOI":"10.18632\/aging.103074","article-title":"Autophagy prevents hippocampal \u03b1-synuclein oligomerization and early cognitive dysfunction after anesthesia\/surgery in aged rats","volume":"12","author":"Yang","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.arr.2025.102684_bib153","doi-asserted-by":"crossref","DOI":"10.1177\/1179573520907397","article-title":"Current and future treatments in Alzheimer disease: an update","volume":"12","author":"Yiannopoulou","year":"2020","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"10.1016\/j.arr.2025.102684_bib154","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.3233\/JAD-160430","article-title":"Elevated mRNA expression and low methylation of SNCA in Japanese Alzheimer\u2019s disease subjects","volume":"54","author":"Yoshino","year":"2016","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.arr.2025.102684_bib155","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.brainres.2008.03.019","article-title":"Polymorphisms at the \u03b22-adrenergic receptor gene influence Alzheimer\u2019s disease susceptibility","volume":"1210","author":"Yu","year":"2008","journal-title":"Brain Res"},{"key":"10.1016\/j.arr.2025.102684_bib156","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s40120-018-0122-z","article-title":"Emerging immunotherapies for Parkinson disease","volume":"8","author":"Zella","year":"2019","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.arr.2025.102684_bib157","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.7150\/ijbs.57078","article-title":"Interaction between A\u03b2 and tau in the pathogenesis of Alzheimer\u2019s disease","volume":"17","author":"Zhang","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.arr.2025.102684_bib158","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101464","article-title":"Autophagy in Alzheimer\u2019s disease pathogenesis: Therapeutic potential and future perspectives","volume":"72","author":"Zhang","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2025.102684_bib159","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay1809","article-title":"APOE4 exacerbates \u03b1-synuclein pathology and related toxicity independent of amyloid","volume":"12","author":"Zhao","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.arr.2025.102684_bib160","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/01616412.2020.1716467","article-title":"The prevalence of Alzheimer\u2019s disease in the Chinese Han population: a meta-analysis","volume":"42","author":"Zhao","year":"2020","journal-title":"Neurol. Res."},{"key":"10.1016\/j.arr.2025.102684_bib161","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1021\/acs.jpcb.5b00692","article-title":"Amyloid \u03b2-protein assembly: the effect of molecular tweezers CLR01 and CLR03","volume":"119","author":"Zheng","year":"2015","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.arr.2025.102684_bib162","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.parkreldis.2022.06.001","article-title":"Plasma and serum alpha-synuclein as a biomarker in Parkinson\u2019s disease: a meta-analysis","volume":"99","author":"Zubelzu","year":"2022","journal-title":"Park. Relat. Disord."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163725000303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163725000303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T01:11:22Z","timestamp":1750209082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163725000303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":162,"alternative-id":["S1568163725000303"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2025.102684","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond amyloid plaque, targeting \u03b1-synuclein in Alzheimer disease: The battle continues","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2025.102684","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102684"}}